» Articles » PMID: 33793598

Evaluation of Prognostic Significance of Hematological Profiles After the Intensive Phase Treatment in Pulmonary Tuberculosis Patients from Romania

Overview
Journal PLoS One
Date 2021 Apr 1
PMID 33793598
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated in this cohort study the predictive ability of 23 peripheral blood parameters and ratios for treatment outcomes after the 2-month intensive phase in patients with PTB. In 63 patients out of 90 that turned culture negative, a significant decrease in white blood cell count, neutrophils, monocyte, hemoglobin, platelet, plateletcrit, erythrocyte sedimentation rate, MLR, NLR, PLR and SII values after anti-TB therapy compared to pretreatment was observed (p <0.001). Logistic regression analysis generated a model of predictors consisting of nine covariates. Spearman's correlation analysis revealed significant positive correlations between NLR with NEU (r = 0.79, p<0.01), SII with NEU (r = 0.846, p<0.01), PLT with SII (r = 0.831, p<0.01), PLT with PCT (r = 0.71, p<0.01) and MPV with P-LCR (r = 0,897, p<0.01) in 63 patients out of 90 that turned culture negative after 2 months of treatment. ROC curve analysis indicated that all areas under the curve (AUC) revealed no statistically significant results, except lymphocyte for culture conversion. In summary, here we observed a set of hematological parameters that declined significantly as the disease was treated in patients that turned culture negative. Despite some limitations, our findings are useful for further studies aiming to identify hematological profiles that could predict the treatment outcome.

Citing Articles

Association of Altered Baseline Hematological Parameters with Adverse Tuberculosis Treatment Outcomes.

Nancy Pandiarajan A, Kumar N, Moideen K, Thiruvengadam K, Hissar S, Sivakumar S Pathogens. 2025; 14(2).

PMID: 40005523 PMC: 11857862. DOI: 10.3390/pathogens14020146.


Haematological markers as predictive tools for tuberculosis in PLHIV: a retrospective cohort study in Gujarat, India.

M Y, Vamja R, Parmar P, Makwana N, Sundar R BMC Infect Dis. 2025; 25(1):228.

PMID: 39962402 PMC: 11834239. DOI: 10.1186/s12879-025-10625-y.


Hematological Parameters Predicting Mortality in Patients with COPD Admitted to ICUs.

Alotaibi B, Alsabani M, Alghamdi A, Alotibi R, Al-Mutairi A, Philip W Saudi J Med Med Sci. 2025; 13(1):26-31.

PMID: 39935998 PMC: 11809761. DOI: 10.4103/sjmms.sjmms_276_24.


Bacterial Infections, Trends, and Resistance Patterns in the Time of the COVID-19 Pandemic in Romania-A Systematic Review.

Vulcanescu D, Bagiu I, Avram C, Oprisoni L, Tanasescu S, Sorescu T Antibiotics (Basel). 2025; 13(12.

PMID: 39766609 PMC: 11726834. DOI: 10.3390/antibiotics13121219.


Association Between Indices of Peripheral Blood Inflammation and Cavitary Pulmonary Tuberculosis.

He X, Hou H, Jiang Y, Huang X Int J Gen Med. 2024; 17:5133-5142.

PMID: 39529941 PMC: 11552384. DOI: 10.2147/IJGM.S483185.


References
1.
Kroon E, Coussens A, Kinnear C, Orlova M, Moller M, Seeger A . Neutrophils: Innate Effectors of TB Resistance?. Front Immunol. 2018; 9:2637. PMC: 6246713. DOI: 10.3389/fimmu.2018.02637. View

2.
Baynes R, Flax H, BOTHWELL T, Bezwoda W, Atkinson P, Mendelow B . Red blood cell distribution width in the anemia secondary to tuberculosis. Am J Clin Pathol. 1986; 85(2):226-9. DOI: 10.1093/ajcp/85.2.226. View

3.
Goodman D, Goodman C, Monk J . Use of the neutrophil:lymphocyte ratio in the diagnosis of appendicitis. Am Surg. 1995; 61(3):257-9. View

4.
Wang W, Wang L, Liu Y, Yang F, Zhu L, Zhang X . Value of the Ratio of Monocytes to Lymphocytes for Monitoring Tuberculosis Therapy. Can J Infect Dis Med Microbiol. 2019; 2019:3270393. PMC: 6556807. DOI: 10.1155/2019/3270393. View

5.
Getahun H, Matteelli A, Chaisson R, Raviglione M . Latent Mycobacterium tuberculosis infection. N Engl J Med. 2015; 372(22):2127-35. DOI: 10.1056/NEJMra1405427. View